Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.6.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.6.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.12.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.12.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LZ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LZ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used